We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Rod System Allows Controlled Movement of Adjacent Vertebrae

By HospiMedica staff writers
Posted on 06 Nov 2007
A novel vertebral fusion system improves and expands the surgeon's treatment options and improves patient outcomes by reducing adjacent-level disease caused by traditional fusion surgery.

The Dynamo Rod System contains a flexible rod that allows for 0.75 mm of compression, +/-1.75 degrees of angulation, and features a 5.5-mm diameter rod that is pre-contoured for lordosis in lengths ranging from 65 to 400 mm, which allows for controlled compression, distraction, flexion, and extension. More...
The rod system is designed to promote load sharing between the vertebral body replacement device and the endplates, while reducing stress on the screw to bone interfaces. The Dynamo rod system is manufactured by Alphatec Holdings (Carlsbad, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"Unlike a traditional rigid fusion procedure, Dynamo is designed to allow for controlled compression, distraction, flexion, and extension of vertebrae adjacent to a fusion location, which should enable the patient to have an additional range of motion during the initial healing phase following fusion surgery,” said Dirk Kuyper, president
and CEO of Alphatec.

Advances in spine surgery technology, including a greater focus on the principles of spinal load sharing, has led to a shift toward reconstructing the spine in a way that reproduces normal spinal mechanics--a process called dynamic stabilization--with instrumentation that is rigid enough to provide sufficient immobilization while fusion takes place, but not so stiff that it places excessive pressure on the adjacent facets and discs.


Related Links:
Alphatec Holdings

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.